It was over $3 less than 3 weeks ago, on the 31st of March.
To quote Bezos from another post "the share price isn't the company"
What does look good for the company is FTO inhibition, cardio protection, indications in 27 cancers and being the first FTO inhibitor being trialled as an FTO inhibitor in the clinic in about 4-6 weeks and counting
Ann: Bonus Issue of Options - Letter to Eligible Shareholders, page-27
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
0.040(2.93%) |
Mkt cap ! $239.3M | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.50 | $1.35 | $167.2K | 118.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3547 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 2072 | 1 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |